VolitionRx (NYSEMKT:VNRX)

VolitionRx (NYSEMKT:VNRX)


Share Price
$ 3.44
Change
0.08 (2.38 %)
Market Cap
$135.81 m
Proactive Investors - Run By Investors For Investors

VolitionRx

Volition is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid -- an indication that disease is present.

 

EPIC: VNRX
Market: NYSEMKT:VNRX
52-week High/Low: $3.61 / $1.46
Sector: Pharma & Biotech
Market Cap: $135.81 m
Website: volitionrx.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of VolitionRx


VolitionRx Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use